Company: Albert Einstein College of Medicine
Job title: Professor of Biochemistry & Medicine
Dr. Evris Gavathiotis is a Professor of Biochemistry and Medicine at Albert Einstein College of Medicine. He received his B.Sc. in Chemistry at the University of Crete, Greece and his Ph.D. in biological chemistry from the University of Nottingham, UK. He completed postdoctoral research at Rockefeller University and at Dana-Farber Cancer Institute and he was junior faculty at Harvard Medical School. In 2011, he started his lab at Einstein and became tenured full professor in 2019. His research focuses on mechanisms and protein interactions in cell death and cell survival signaling and the discovery and optimization of small molecule modulators towards novel chemical tools and therapeutics. His research has pioneered mechanistic insights of BCL-2 family proteins and other key signaling proteins. He has discovered first-in-class small molecules for several “undruggable” targets and demonstrated novel pharmacological strategies. His research has contributed to the founding of three biotechnology companies (Stelexis Therapeutics, Selphagy Therapeutics, Aspida Therapeutics) that are advancing novel therapeutics for cancer and aging-associated diseases. Dr. Gavathiotis has received numerous awards for his research including the Sidney Kimmel Scholar Award, the 2014 Young Chemical Biologist Award, the Pershing Square Sohn Prize and the Irma T. Hirschl Career Scientist Award.
Discussion/Q&A 10:00 am
day: Day Two
Harnessing Structure-Based Technologies for Novel Target and Drug Discovery 9:00 am
Highlighting structural and computational approaches to characterize interactions of small molecules and dynamic targets Providing structural information on novel targets and allosteric pockets for drug design Developing activators and inhibitors for dynamic protein-protein interaction targetsRead more
day: Day Two